Medical Care

Global Carcinoembryonic Antigen (CEA) Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Carcinoembryonic Antigen (CEA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carcinoembryonic Antigen (CEA).
The Carcinoembryonic Antigen (CEA) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Carcinoembryonic Antigen (CEA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carcinoembryonic Antigen (CEA) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Diagnostics
Abbott Diagnostics
Quest Diagnostics
Segment by Type
CD66a
CD66b
CD66c
CD66d
CD66e
CD66f
Segment by Application
Colorectal Cancer
Pancreatic Cancer
Ovarian Cancer
Breast Cancer
Thyroid Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Carcinoembryonic Antigen (CEA) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CD66a
1.2.3 CD66b
1.2.4 CD66c
1.2.5 CD66d
1.2.6 CD66e
1.2.7 CD66f
1.3 Market by Application
1.3.1 Global Carcinoembryonic Antigen (CEA) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Colorectal Cancer
1.3.3 Pancreatic Cancer
1.3.4 Ovarian Cancer
1.3.5 Breast Cancer
1.3.6 Thyroid Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Carcinoembryonic Antigen (CEA) Market Perspective (2020-2031)
2.2 Global Carcinoembryonic Antigen (CEA) Growth Trends by Region
2.2.1 Global Carcinoembryonic Antigen (CEA) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Carcinoembryonic Antigen (CEA) Historic Market Size by Region (2020-2025)
2.2.3 Carcinoembryonic Antigen (CEA) Forecasted Market Size by Region (2026-2031)
2.3 Carcinoembryonic Antigen (CEA) Market Dynamics
2.3.1 Carcinoembryonic Antigen (CEA) Industry Trends
2.3.2 Carcinoembryonic Antigen (CEA) Market Drivers
2.3.3 Carcinoembryonic Antigen (CEA) Market Challenges
2.3.4 Carcinoembryonic Antigen (CEA) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Carcinoembryonic Antigen (CEA) Players by Revenue
3.1.1 Global Top Carcinoembryonic Antigen (CEA) Players by Revenue (2020-2025)
3.1.2 Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Players (2020-2025)
3.2 Global Carcinoembryonic Antigen (CEA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Carcinoembryonic Antigen (CEA) Revenue
3.4 Global Carcinoembryonic Antigen (CEA) Market Concentration Ratio
3.4.1 Global Carcinoembryonic Antigen (CEA) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Carcinoembryonic Antigen (CEA) Revenue in 2024
3.5 Global Key Players of Carcinoembryonic Antigen (CEA) Head office and Area Served
3.6 Global Key Players of Carcinoembryonic Antigen (CEA), Product and Application
3.7 Global Key Players of Carcinoembryonic Antigen (CEA), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Carcinoembryonic Antigen (CEA) Breakdown Data by Type
4.1 Global Carcinoembryonic Antigen (CEA) Historic Market Size by Type (2020-2025)
4.2 Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Type (2026-2031)
5 Carcinoembryonic Antigen (CEA) Breakdown Data by Application
5.1 Global Carcinoembryonic Antigen (CEA) Historic Market Size by Application (2020-2025)
5.2 Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Carcinoembryonic Antigen (CEA) Market Size (2020-2031)
6.2 North America Carcinoembryonic Antigen (CEA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Carcinoembryonic Antigen (CEA) Market Size by Country (2020-2025)
6.4 North America Carcinoembryonic Antigen (CEA) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Carcinoembryonic Antigen (CEA) Market Size (2020-2031)
7.2 Europe Carcinoembryonic Antigen (CEA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Carcinoembryonic Antigen (CEA) Market Size by Country (2020-2025)
7.4 Europe Carcinoembryonic Antigen (CEA) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size (2020-2031)
8.2 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Region (2020-2025)
8.4 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Carcinoembryonic Antigen (CEA) Market Size (2020-2031)
9.2 Latin America Carcinoembryonic Antigen (CEA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Carcinoembryonic Antigen (CEA) Market Size by Country (2020-2025)
9.4 Latin America Carcinoembryonic Antigen (CEA) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size (2020-2031)
10.2 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Country (2020-2025)
10.4 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Details
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Carcinoembryonic Antigen (CEA) Introduction
11.1.4 Roche Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2020-2025)
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott Diagnostics
11.2.1 Abbott Diagnostics Company Details
11.2.2 Abbott Diagnostics Business Overview
11.2.3 Abbott Diagnostics Carcinoembryonic Antigen (CEA) Introduction
11.2.4 Abbott Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2020-2025)
11.2.5 Abbott Diagnostics Recent Development
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Company Details
11.3.2 Quest Diagnostics Business Overview
11.3.3 Quest Diagnostics Carcinoembryonic Antigen (CEA) Introduction
11.3.4 Quest Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2020-2025)
11.3.5 Quest Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CD66a
Table 3. Key Players of CD66b
Table 4. Key Players of CD66c
Table 5. Key Players of CD66d
Table 6. Key Players of CD66e
Table 7. Key Players of CD66f
Table 8. Global Carcinoembryonic Antigen (CEA) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Carcinoembryonic Antigen (CEA) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Carcinoembryonic Antigen (CEA) Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Carcinoembryonic Antigen (CEA) Market Share by Region (2020-2025)
Table 12. Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Carcinoembryonic Antigen (CEA) Market Share by Region (2026-2031)
Table 14. Carcinoembryonic Antigen (CEA) Market Trends
Table 15. Carcinoembryonic Antigen (CEA) Market Drivers
Table 16. Carcinoembryonic Antigen (CEA) Market Challenges
Table 17. Carcinoembryonic Antigen (CEA) Market Restraints
Table 18. Global Carcinoembryonic Antigen (CEA) Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Carcinoembryonic Antigen (CEA) Market Share by Players (2020-2025)
Table 20. Global Top Carcinoembryonic Antigen (CEA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carcinoembryonic Antigen (CEA) as of 2024)
Table 21. Ranking of Global Top Carcinoembryonic Antigen (CEA) Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Carcinoembryonic Antigen (CEA) Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Carcinoembryonic Antigen (CEA), Headquarters and Area Served
Table 24. Global Key Players of Carcinoembryonic Antigen (CEA), Product and Application
Table 25. Global Key Players of Carcinoembryonic Antigen (CEA), Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Carcinoembryonic Antigen (CEA) Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Type (2020-2025)
Table 29. Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Type (2026-2031)
Table 31. Global Carcinoembryonic Antigen (CEA) Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Application (2020-2025)
Table 33. Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Application (2026-2031)
Table 35. North America Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Carcinoembryonic Antigen (CEA) Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Carcinoembryonic Antigen (CEA) Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Carcinoembryonic Antigen (CEA) Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Carcinoembryonic Antigen (CEA) Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Carcinoembryonic Antigen (CEA) Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Carcinoembryonic Antigen (CEA) Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Country (2026-2031) & (US$ Million)
Table 50. Roche Diagnostics Company Details
Table 51. Roche Diagnostics Business Overview
Table 52. Roche Diagnostics Carcinoembryonic Antigen (CEA) Product
Table 53. Roche Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2020-2025) & (US$ Million)
Table 54. Roche Diagnostics Recent Development
Table 55. Abbott Diagnostics Company Details
Table 56. Abbott Diagnostics Business Overview
Table 57. Abbott Diagnostics Carcinoembryonic Antigen (CEA) Product
Table 58. Abbott Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2020-2025) & (US$ Million)
Table 59. Abbott Diagnostics Recent Development
Table 60. Quest Diagnostics Company Details
Table 61. Quest Diagnostics Business Overview
Table 62. Quest Diagnostics Carcinoembryonic Antigen (CEA) Product
Table 63. Quest Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2020-2025) & (US$ Million)
Table 64. Quest Diagnostics Recent Development
Table 65. Research Programs/Design for This Report
Table 66. Key Data Information from Secondary Sources
Table 67. Key Data Information from Primary Sources
Table 68. Authors List of This Report


List of Figures
Figure 1. Carcinoembryonic Antigen (CEA) Picture
Figure 2. Global Carcinoembryonic Antigen (CEA) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Carcinoembryonic Antigen (CEA) Market Share by Type: 2024 VS 2031
Figure 4. CD66a Features
Figure 5. CD66b Features
Figure 6. CD66c Features
Figure 7. CD66d Features
Figure 8. CD66e Features
Figure 9. CD66f Features
Figure 10. Global Carcinoembryonic Antigen (CEA) Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Carcinoembryonic Antigen (CEA) Market Share by Application: 2024 VS 2031
Figure 12. Colorectal Cancer Case Studies
Figure 13. Pancreatic Cancer Case Studies
Figure 14. Ovarian Cancer Case Studies
Figure 15. Breast Cancer Case Studies
Figure 16. Thyroid Cancer Case Studies
Figure 17. Others Case Studies
Figure 18. Carcinoembryonic Antigen (CEA) Report Years Considered
Figure 19. Global Carcinoembryonic Antigen (CEA) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 20. Global Carcinoembryonic Antigen (CEA) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global Carcinoembryonic Antigen (CEA) Market Share by Region: 2024 VS 2031
Figure 22. Global Carcinoembryonic Antigen (CEA) Market Share by Players in 2024
Figure 23. Global Top Carcinoembryonic Antigen (CEA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carcinoembryonic Antigen (CEA) as of 2024)
Figure 24. The Top 10 and 5 Players Market Share by Carcinoembryonic Antigen (CEA) Revenue in 2024
Figure 25. North America Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. North America Carcinoembryonic Antigen (CEA) Market Share by Country (2020-2031)
Figure 27. United States Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Canada Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Europe Carcinoembryonic Antigen (CEA) Market Share by Country (2020-2031)
Figure 31. Germany Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. France Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. U.K. Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Italy Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Russia Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Nordic Countries Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Share by Region (2020-2031)
Figure 39. China Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Japan Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. South Korea Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. India Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Australia Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Latin America Carcinoembryonic Antigen (CEA) Market Share by Country (2020-2031)
Figure 47. Mexico Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Brazil Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Share by Country (2020-2031)
Figure 51. Turkey Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. UAE Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Roche Diagnostics Revenue Growth Rate in Carcinoembryonic Antigen (CEA) Business (2020-2025)
Figure 55. Abbott Diagnostics Revenue Growth Rate in Carcinoembryonic Antigen (CEA) Business (2020-2025)
Figure 56. Quest Diagnostics Revenue Growth Rate in Carcinoembryonic Antigen (CEA) Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies